img

Global Schistosomiasis Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Schistosomiasis Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Schistosomiasis Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Schistosomiasis Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Pharmacy Retail are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Schistosomiasis Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Schistosomiasis Drugs key manufacturers include Pfizer, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals and Shin Poong, etc. Pfizer, Merck, Bayer are top 3 players and held % sales share in total in 2022.
Schistosomiasis Drugs can be divided into Praziquantel (PZQ), Oxaminiquine (OXA) and Others,, etc. Praziquantel (PZQ) is the mainstream product in the market, accounting for % sales share globally in 2022.
Schistosomiasis Drugs is widely used in various fields, such as Hospital, Pharmacy Retail and Others,, etc. Hospital provides greatest supports to the Schistosomiasis Drugs industry development. In 2022, global % sales of Schistosomiasis Drugs went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Schistosomiasis Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Shin Poong
Segment by Type
Praziquantel (PZQ)
Oxaminiquine (OXA)
Others

Segment by Application


Hospital
Pharmacy Retail
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Schistosomiasis Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Schistosomiasis Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Schistosomiasis Drugs industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Schistosomiasis Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Schistosomiasis Drugs introduction, etc. Schistosomiasis Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Schistosomiasis Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Schistosomiasis Drugs Market Overview
1.1 Schistosomiasis Drugs Product Overview
1.2 Schistosomiasis Drugs Market Segment by Type
1.2.1 Praziquantel (PZQ)
1.2.2 Oxaminiquine (OXA)
1.2.3 Others
1.3 Global Schistosomiasis Drugs Market Size by Type
1.3.1 Global Schistosomiasis Drugs Market Size Overview by Type (2024-2034)
1.3.2 Global Schistosomiasis Drugs Historic Market Size Review by Type (2024-2024)
1.3.3 Global Schistosomiasis Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Schistosomiasis Drugs Sales Breakdown by Type (2024-2024)
1.4.2 Europe Schistosomiasis Drugs Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Schistosomiasis Drugs Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Schistosomiasis Drugs Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Schistosomiasis Drugs Sales Breakdown by Type (2024-2024)
2 Global Schistosomiasis Drugs Market Competition by Company
2.1 Global Top Players by Schistosomiasis Drugs Sales (2024-2024)
2.2 Global Top Players by Schistosomiasis Drugs Revenue (2024-2024)
2.3 Global Top Players by Schistosomiasis Drugs Price (2024-2024)
2.4 Global Top Manufacturers Schistosomiasis Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Schistosomiasis Drugs Market Competitive Situation and Trends
2.5.1 Schistosomiasis Drugs Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Schistosomiasis Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Schistosomiasis Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Schistosomiasis Drugs Market
2.8 Key Manufacturers Schistosomiasis Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Schistosomiasis Drugs Status and Outlook by Region
3.1 Global Schistosomiasis Drugs Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Schistosomiasis Drugs Historic Market Size by Region
3.2.1 Global Schistosomiasis Drugs Sales in Volume by Region (2024-2024)
3.2.2 Global Schistosomiasis Drugs Sales in Value by Region (2024-2024)
3.2.3 Global Schistosomiasis Drugs Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Schistosomiasis Drugs Forecasted Market Size by Region
3.3.1 Global Schistosomiasis Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Schistosomiasis Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Schistosomiasis Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Schistosomiasis Drugs by Application
4.1 Schistosomiasis Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy Retail
4.1.3 Others
4.2 Global Schistosomiasis Drugs Market Size by Application
4.2.1 Global Schistosomiasis Drugs Market Size Overview by Application (2024-2034)
4.2.2 Global Schistosomiasis Drugs Historic Market Size Review by Application (2024-2024)
4.2.3 Global Schistosomiasis Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Schistosomiasis Drugs Sales Breakdown by Application (2024-2024)
4.3.2 Europe Schistosomiasis Drugs Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Schistosomiasis Drugs Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Schistosomiasis Drugs Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Schistosomiasis Drugs Sales Breakdown by Application (2024-2024)
5 North America Schistosomiasis Drugs by Country
5.1 North America Schistosomiasis Drugs Historic Market Size by Country
5.1.1 North America Schistosomiasis Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Schistosomiasis Drugs Sales in Volume by Country (2024-2024)
5.1.3 North America Schistosomiasis Drugs Sales in Value by Country (2024-2024)
5.2 North America Schistosomiasis Drugs Forecasted Market Size by Country
5.2.1 North America Schistosomiasis Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Schistosomiasis Drugs Sales in Value by Country (2024-2034)
6 Europe Schistosomiasis Drugs by Country
6.1 Europe Schistosomiasis Drugs Historic Market Size by Country
6.1.1 Europe Schistosomiasis Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Schistosomiasis Drugs Sales in Volume by Country (2024-2024)
6.1.3 Europe Schistosomiasis Drugs Sales in Value by Country (2024-2024)
6.2 Europe Schistosomiasis Drugs Forecasted Market Size by Country
6.2.1 Europe Schistosomiasis Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Schistosomiasis Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Schistosomiasis Drugs by Region
7.1 Asia-Pacific Schistosomiasis Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Schistosomiasis Drugs Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Schistosomiasis Drugs Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Schistosomiasis Drugs Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Schistosomiasis Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Schistosomiasis Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Schistosomiasis Drugs Sales in Value by Region (2024-2034)
8 Latin America Schistosomiasis Drugs by Country
8.1 Latin America Schistosomiasis Drugs Historic Market Size by Country
8.1.1 Latin America Schistosomiasis Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Schistosomiasis Drugs Sales in Volume by Country (2024-2024)
8.1.3 Latin America Schistosomiasis Drugs Sales in Value by Country (2024-2024)
8.2 Latin America Schistosomiasis Drugs Forecasted Market Size by Country
8.2.1 Latin America Schistosomiasis Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Schistosomiasis Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Schistosomiasis Drugs by Country
9.1 Middle East and Africa Schistosomiasis Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Schistosomiasis Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Schistosomiasis Drugs Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Schistosomiasis Drugs Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Schistosomiasis Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Schistosomiasis Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Schistosomiasis Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Schistosomiasis Drugs Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Pfizer Schistosomiasis Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Schistosomiasis Drugs Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck Schistosomiasis Drugs Products Offered
10.2.5 Merck Recent Development
10.3 Bayer
10.3.1 Bayer Company Information
10.3.2 Bayer Introduction and Business Overview
10.3.3 Bayer Schistosomiasis Drugs Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Bayer Schistosomiasis Drugs Products Offered
10.3.5 Bayer Recent Development
10.4 EIPICO
10.4.1 EIPICO Company Information
10.4.2 EIPICO Introduction and Business Overview
10.4.3 EIPICO Schistosomiasis Drugs Sales, Revenue and Gross Margin (2024-2024)
10.4.4 EIPICO Schistosomiasis Drugs Products Offered
10.4.5 EIPICO Recent Development
10.5 Chandra Bhagat Pharma
10.5.1 Chandra Bhagat Pharma Company Information
10.5.2 Chandra Bhagat Pharma Introduction and Business Overview
10.5.3 Chandra Bhagat Pharma Schistosomiasis Drugs Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Chandra Bhagat Pharma Schistosomiasis Drugs Products Offered
10.5.5 Chandra Bhagat Pharma Recent Development
10.6 Taj Pharmaceuticals
10.6.1 Taj Pharmaceuticals Company Information
10.6.2 Taj Pharmaceuticals Introduction and Business Overview
10.6.3 Taj Pharmaceuticals Schistosomiasis Drugs Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Taj Pharmaceuticals Schistosomiasis Drugs Products Offered
10.6.5 Taj Pharmaceuticals Recent Development
10.7 Shin Poong
10.7.1 Shin Poong Company Information
10.7.2 Shin Poong Introduction and Business Overview
10.7.3 Shin Poong Schistosomiasis Drugs Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Shin Poong Schistosomiasis Drugs Products Offered
10.7.5 Shin Poong Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Schistosomiasis Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Schistosomiasis Drugs Industrial Chain Analysis
11.4 Schistosomiasis Drugs Market Dynamics
11.4.1 Schistosomiasis Drugs Industry Trends
11.4.2 Schistosomiasis Drugs Market Drivers
11.4.3 Schistosomiasis Drugs Market Challenges
11.4.4 Schistosomiasis Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Schistosomiasis Drugs Distributors
12.3 Schistosomiasis Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Praziquantel (PZQ)
Table 2. Major Company of Oxaminiquine (OXA)
Table 3. Major Company of Others
Table 4. Global Schistosomiasis Drugs Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Schistosomiasis Drugs Sales by Type (2024-2024) & (K Units)
Table 6. Global Schistosomiasis Drugs Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Schistosomiasis Drugs Sales by Type (2024-2024) & (US& Million)
Table 8. Global Schistosomiasis Drugs Market Share in Value by Type (2024-2024)
Table 9. Global Schistosomiasis Drugs Price by Type (2024-2024) & (US$/Unit)
Table 10. Global Schistosomiasis Drugs Sales by Type (2024-2034) & (K Units)
Table 11. Global Schistosomiasis Drugs Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Schistosomiasis Drugs Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Schistosomiasis Drugs Sales Market Share in Value by Type (2024-2034)
Table 14. Global Schistosomiasis Drugs Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Schistosomiasis Drugs Sales by Type (2024-2024) & (K Units)
Table 16. North America Schistosomiasis Drugs Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Schistosomiasis Drugs Sales (K Units) by Type (2024-2024)
Table 18. Europe Schistosomiasis Drugs Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Schistosomiasis Drugs Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific Schistosomiasis Drugs Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Schistosomiasis Drugs Sales (K Units) by Type (2024-2024)
Table 22. Latin America Schistosomiasis Drugs Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Schistosomiasis Drugs Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa Schistosomiasis Drugs Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Schistosomiasis Drugs Sales by Company (2024-2024) & (K Units)
Table 26. Global Schistosomiasis Drugs Sales Share by Company (2024-2024)
Table 27. Global Schistosomiasis Drugs Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Schistosomiasis Drugs Revenue Share by Company (2024-2024)
Table 29. Global Market Schistosomiasis Drugs Price by Company (2024-2024) & (US$/Unit)
Table 30. Global Schistosomiasis Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Schistosomiasis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Schistosomiasis Drugs as of 2022)
Table 33. Date of Key Manufacturers Enter into Schistosomiasis Drugs Market
Table 34. Key Manufacturers Schistosomiasis Drugs Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Schistosomiasis Drugs Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Schistosomiasis Drugs Sales by Region (2024-2024) & (K Units)
Table 38. Global Schistosomiasis Drugs Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Schistosomiasis Drugs Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Schistosomiasis Drugs Sales Market Share in Value by Region (2024-2024)
Table 41. Global Schistosomiasis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 42. Global Schistosomiasis Drugs Sales by Region (2024-2034) & (K Units)
Table 43. Global Schistosomiasis Drugs Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Schistosomiasis Drugs Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Schistosomiasis Drugs Sales Market Share in Value by Region (2024-2034)
Table 46. Global Schistosomiasis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Schistosomiasis Drugs Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Schistosomiasis Drugs Sales by Application (2024-2024) & (K Units)
Table 49. Global Schistosomiasis Drugs Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Schistosomiasis Drugs Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Schistosomiasis Drugs Sales Market Share in Value by Application (2024-2024)
Table 52. Global Schistosomiasis Drugs Price by Application (2024-2024) & (US$/Unit)
Table 53. Global Schistosomiasis Drugs Sales by Application (2024-2034) & (K Units)
Table 54. Global Schistosomiasis Drugs Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Schistosomiasis Drugs Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Schistosomiasis Drugs Sales Market Share in Value by Application (2024-2034)
Table 57. Global Schistosomiasis Drugs Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Schistosomiasis Drugs Sales by Application (2024-2024) (K Units)
Table 59. North America Schistosomiasis Drugs Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Schistosomiasis Drugs Sales by Application (2024-2024) (K Units)
Table 61. Europe Schistosomiasis Drugs Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Schistosomiasis Drugs Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific Schistosomiasis Drugs Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Schistosomiasis Drugs Sales by Application (2024-2024) (K Units)
Table 65. Latin America Schistosomiasis Drugs Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Schistosomiasis Drugs Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa Schistosomiasis Drugs Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Schistosomiasis Drugs Sales by Country (2024-2024) & (K Units)
Table 69. North America Schistosomiasis Drugs Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Schistosomiasis Drugs Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Schistosomiasis Drugs Sales Market Share in Value by Country (2024-2024)
Table 72. North America Schistosomiasis Drugs Sales by Country (2024-2034) & (K Units)
Table 73. North America Schistosomiasis Drugs Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Schistosomiasis Drugs Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Schistosomiasis Drugs Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Schistosomiasis Drugs Sales by Country (2024-2024) & (K Units)
Table 77. Europe Schistosomiasis Drugs Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Schistosomiasis Drugs Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Schistosomiasis Drugs Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Schistosomiasis Drugs Sales by Country (2024-2034) & (K Units)
Table 81. Europe Schistosomiasis Drugs Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Schistosomiasis Drugs Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Schistosomiasis Drugs Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Schistosomiasis Drugs Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific Schistosomiasis Drugs Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Schistosomiasis Drugs Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Schistosomiasis Drugs Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Schistosomiasis Drugs Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Schistosomiasis Drugs Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Schistosomiasis Drugs Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Schistosomiasis Drugs Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Schistosomiasis Drugs Sales by Country (2024-2024) & (K Units)
Table 93. Latin America Schistosomiasis Drugs Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Schistosomiasis Drugs Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Schistosomiasis Drugs Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Schistosomiasis Drugs Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Schistosomiasis Drugs Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Schistosomiasis Drugs Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Schistosomiasis Drugs Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Schistosomiasis Drugs Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa Schistosomiasis Drugs Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Schistosomiasis Drugs Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Schistosomiasis Drugs Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Schistosomiasis Drugs Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Schistosomiasis Drugs Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Schistosomiasis Drugs Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Schistosomiasis Drugs Sales Market Share in Value by Country (2024-2034)
Table 108. Pfizer Company Information
Table 109. Pfizer Introduction and Business Overview
Table 110. Pfizer Schistosomiasis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. Pfizer Schistosomiasis Drugs Product
Table 112. Pfizer Recent Development
Table 113. Merck Company Information
Table 114. Merck Introduction and Business Overview
Table 115. Merck Schistosomiasis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. Merck Schistosomiasis Drugs Product
Table 117. Merck Recent Development
Table 118. Bayer Company Information
Table 119. Bayer Introduction and Business Overview
Table 120. Bayer Schistosomiasis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. Bayer Schistosomiasis Drugs Product
Table 122. Bayer Recent Development
Table 123. EIPICO Company Information
Table 124. EIPICO Introduction and Business Overview
Table 125. EIPICO Schistosomiasis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. EIPICO Schistosomiasis Drugs Product
Table 127. EIPICO Recent Development
Table 128. Chandra Bhagat Pharma Company Information
Table 129. Chandra Bhagat Pharma Introduction and Business Overview
Table 130. Chandra Bhagat Pharma Schistosomiasis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Chandra Bhagat Pharma Schistosomiasis Drugs Product
Table 132. Chandra Bhagat Pharma Recent Development
Table 133. Taj Pharmaceuticals Company Information
Table 134. Taj Pharmaceuticals Introduction and Business Overview
Table 135. Taj Pharmaceuticals Schistosomiasis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Taj Pharmaceuticals Schistosomiasis Drugs Product
Table 137. Taj Pharmaceuticals Recent Development
Table 138. Shin Poong Company Information
Table 139. Shin Poong Introduction and Business Overview
Table 140. Shin Poong Schistosomiasis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 141. Shin Poong Schistosomiasis Drugs Product
Table 142. Shin Poong Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Schistosomiasis Drugs Market Trends
Table 146. Schistosomiasis Drugs Market Drivers
Table 147. Schistosomiasis Drugs Market Challenges
Table 148. Schistosomiasis Drugs Market Restraints
Table 149. Schistosomiasis Drugs Distributors List
Table 150. Schistosomiasis Drugs Downstream Customers
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Schistosomiasis Drugs Product Picture
Figure 2. Global Schistosomiasis Drugs Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Schistosomiasis Drugs Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Schistosomiasis Drugs Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Praziquantel (PZQ)
Figure 6. Global Praziquantel (PZQ) Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Oxaminiquine (OXA)
Figure 8. Global Oxaminiquine (OXA) Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global Schistosomiasis Drugs Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Schistosomiasis Drugs Sales Market Share by Type in 2022 & 2034
Figure 13. North America Schistosomiasis Drugs Sales Market Share in Volume by Type in 2022
Figure 14. North America Schistosomiasis Drugs Sales Market Share in Value by Type in 2022
Figure 15. Europe Schistosomiasis Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Europe Schistosomiasis Drugs Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Schistosomiasis Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Schistosomiasis Drugs Sales Market Share in Value by Type in 2022
Figure 19. Latin America Schistosomiasis Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Schistosomiasis Drugs Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Schistosomiasis Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Schistosomiasis Drugs Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Schistosomiasis Drugs Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Schistosomiasis Drugs Revenue in 2022
Figure 25. Schistosomiasis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Pharmacy Retail
Figure 29. Global Pharmacy Retail Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Global Schistosomiasis Drugs Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Schistosomiasis Drugs Sales Market Share by Application in 2022 & 2034
Figure 34. North America Schistosomiasis Drugs Sales Market Share in Volume by Application in 2022
Figure 35. North America Schistosomiasis Drugs Sales Market Share in Value by Application in 2022
Figure 36. Europe Schistosomiasis Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Europe Schistosomiasis Drugs Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Schistosomiasis Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Schistosomiasis Drugs Sales Market Share in Value by Application in 2022
Figure 40. Latin America Schistosomiasis Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Schistosomiasis Drugs Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Schistosomiasis Drugs Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Schistosomiasis Drugs Manufacturing Cost Structure
Figure 45. Schistosomiasis Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed